The effect of benzodiazepines on insomnia in patients with chronic obstructive pulmonary disease: A meta-analysis of treatment efficacy and safety

International Journal of COPD

Volumn 11, Issue 1, 2016, Pages 675-685

  Lu, Xiao Min ^a   Zhu, Ji Ping ^a   Zhou, Xian Mei ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Benzodiazepine; COPD; Efficacy; Insomnia; Meta analysis; Safety

Indexed keywords

BENZODIAZEPINE DERIVATIVE; FLUNITRAZEPAM; FLURAZEPAM; NITRAZEPAM; PLACEBO; TEMAZEPAM; TRIAZOLAM;

APNEA HYPOPNEA INDEX; AROUSAL; ARTERIAL OXYGEN SATURATION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL (TOPIC); COMORBIDITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; INSOMNIA; META ANALYSIS; OUTCOME ASSESSMENT; SLEEP EFFICIENCY; SLEEP PARAMETERS; SLEEP QUALITY; SLEEP TIME; TRANSCUTANEOUS CARBON DIOXIDE MONITORING; COMPLICATION; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME;

BENZODIAZEPINES; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME;

EID: 84962683421     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S98082     Document Type: Article

References (24)

1. Budhiraja R, Siddiqi TA, Quan SF. Sleep disorders in chronic obstructive pulmonary disease: etiology, impact, and management. J Clin Sleep Med. 2015; 11(3): 259-270.
2. Hynninen MJ, Pallesen S, Hardie J, et al. Insomnia symptoms, objectively measured sleep, and disease severity in chronic obstructive pulmonary disease outpatients. Sleep Med. 2013; 14(12): 1328-1333.
3. Omachi TA, Blanc PD, Claman DM, et al. Disturbed sleep among COPD patients is longitudinally associated with mortality and adverse COPD outcomes. Sleep Med. 2012; 13(5): 476-483.
4. Budhiraja R, Parthasarathy S, Budhiraja P, Habib MP, Wendel C, Quan SF. Insomnia in patients with COPD. Sleep. 2012; 35(3): 369-375.
5. Roth T. Hypnotic use for insomnia management in chronic obstructive pulmonary disease. Sleep Med. 2009; 10(1): 19-25.
6. Vozoris NT, Fischer HD, Wang X, et al. Benzodiazepine use among older adults with chronic obstructive pulmonary disease. Drugs Aging. 2013; 30(3): 183-192.
7. Vozoris NT, Fischer HD, Wang X, et al. Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J. 2014; 44(2): 332-340.
8. Billioti de Gage S, Bégaud B, Bazin F, et al. Benzodiazepine use and risk of dementia: prospective population based study. BMJ. 2012; 345: e6231.
9. Chung WS, Lai CY, Lin CL, Kao CH. Adverse respiratory events associated with hypnotics use in patients of chronic obstructive pulmonary disease: a population-based case-control study. Medicine (Baltimore). 2015; 94(27): e1110.
10. Chen SJ, Yeh CM, Chao TF, et al. The use of benzodiazepine receptor agonists and risk of respiratory failure in patients with chronic obstructive pulmonary disease: a nationwide population-based case-control study. Sleep. 2015; 38(7): 1045-1050.
11. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004; 23(6): 932-946.
12. Halvorsen T, Martinussen PE. Benzodiazepine use in COPD: empirical evidence from Norway. Int J Chron Obstruct Pulmon Dis. 2015; 10: 1695-1702.
13. Stege G, Heijdra YF, van den Elshout FJ, et al. Temazepam 10 mg does not affect breathing and gas exchange in patients with severe normocapnic COPD. Respir Med. 2010; 104(4): 518-524.
14. Block AJ, Dolly FR, Slayton PC. Does flurazepam ingestion affect breathing and oxygenation during sleep in patients with chronic obstructive lung disease? Am Rev Respir Dis. 1984; 129(2): 230-233.
15. Timms RM, Dawson A, Hajdukovic RM, Mitler MM. Effect of triazolam on sleep and arterial oxygen saturation in patients with chronic obstructive pulmonary disease. Arch Intern Med. 1988; 148(10): 2159-2163.
16. Midgren B, Hansson L, Skeidsvoll H, Elmqvist D. The effects of nitrazepam and flunitrazepam on oxygen desaturation during sleep in patients with stable hypoxemic nonhypercapnic COPD. Chest. 1989; 95(4): 765-768.
17. Steens RD, Pouliot Z, Millar TW, Kryger MH, George CF. Effects of zolpidem and triazolam on sleep and respiration in mild to moderate chronic obstructive pulmonary disease. Sleep. 1993; 16(4): 318-326.
18. Raherison C, Girodet PO. Epidemiology of COPD. Eur Respir Rev. 2009; 18(114): 213-221.
19. Urbano F, Mohsenin V. Chronic obstructive pulmonary disease and sleep: the interaction. Panminerva Med. 2006; 48(4): 223-230.
20. Berry RB, McCasland CR, Light RW. The effect of triazolam on the arousal response to airway occlusion during sleep in normal subjects. Am Rev Respir Dis. 1992; 146(5 Pt 1): 1256-1260.
21. Ekström MP, Bornefalk-Hermansson A, Abernethy AP, Currow DC. Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study. BMJ. 2014; 348: g445.
22. Bogunovic OJ, Greenfield SF. Practical geriatrics: use of benzodiazepines among elderly patients. Psychiatr Serv. 2004; 55(3): 233-235.
23. Asnaashari AM, Talaei A, Haghigh B. Evaluation of psychological states in patients with asthma and COPD. Iran J Allergy Asthma Immunol. 2012; 11(1): 65-71.
24. Chen SJ, Yeh CM, Chao TF, et al. The use of benzodiazepine receptor agonists and risk of respiratory failure in patients with chronic obstructive pulmonary disease: a nationwide population-based case-control study. Sleep. 2015; 38(7): 1045-1050.